Xbrane Biopharma AB (XBRANE) — Financial Flexibility Index
Xbrane Biopharma AB (XBRANE) has a Financial Flexibility Index of 0.65x as of December 2025. Free cash flow of Skr72.08 Million (operating CF Skr-67.56 Million minus capex Skr139.64 Million) represents 1% of total liabilities (Skr110.97 Million). Also explore XBRANE net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xbrane Biopharma AB Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Xbrane Biopharma AB across 13 annual periods. Check Xbrane Biopharma AB strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Xbrane Biopharma AB (2013–2025)
Year-by-year free cash flow to debt coverage for Xbrane Biopharma AB. For the full company profile including market capitalisation, see Xbrane Biopharma AB market capitalisation.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | Skr-111.05 Million | Skr-250.69 Million | Skr110.97 Million | ▼ -678.5% |
| 2024 | -0.13x | Skr-81.48 Million | Skr-133.73 Million | Skr633.89 Million | ▲ +84.1% |
| 2023 | -0.81x | Skr-389.91 Million | Skr-406.68 Million | Skr482.17 Million | ▼ -60.5% |
| 2022 | -0.50x | Skr-133.79 Million | Skr-193.92 Million | Skr265.63 Million | ▲ +9.1% |
| 2021 | -0.55x | Skr-142.26 Million | Skr-219.61 Million | Skr256.69 Million | ▲ +51.3% |
| 2020 | -1.14x | Skr-234.55 Million | Skr-238.41 Million | Skr206.06 Million | ▼ -19.4% |
| 2019 | -0.95x | Skr-147.40 Million | Skr-148.59 Million | Skr154.62 Million | ▼ -435.1% |
| 2018 | 0.28x | Skr48.30 Million | Skr46.71 Million | Skr169.81 Million | ▲ +119.2% |
| 2017 | -1.49x | Skr-33.50 Million | Skr-36.85 Million | Skr22.55 Million | ▲ +41.3% |
| 2016 | -2.53x | Skr-27.34 Million | Skr-39.43 Million | Skr10.81 Million | ▼ -526.0% |
| 2015 | -0.40x | Skr-11.24 Million | Skr-12.39 Million | Skr27.82 Million | ▲ +93.6% |
| 2014 | -6.35x | Skr-2.48 Million | Skr-2.67 Million | Skr390.70K | ▼ -46.1% |
| 2013 | -4.35x | Skr-2.20 Million | Skr-2.20 Million | Skr505.44K | — |